A longitudinal study of bioavailable IL-6, soluble CD30 and soluble CD26 (DPPIV) activity in HIV patients who experienced an immune restoration disease after commencing highly active anti-retroviral therapy

Shelley Stone, Patricia Price, J. Brochier, N.M. Keane, Silvia Lee, Martyn French

Research output: Chapter in Book/Conference paperOther chapter contribution

Original languageEnglish
Title of host publicationAustralasian Soc for Immunology Inc. Canberra, Australia. 31st Annual Scientific Mtg. Program & Abstracts. 2-6 Dec 2001
EditorsJ. Altin
Place of PublicationCanberra, Australia
Publication statusPublished - 2001

Cite this